Why Treat girls with Turner Syndrome with Growth Hormone? Growth and Beyond

被引:0
|
作者
Ranke, Michael B. [1 ]
机构
[1] Univ Tubingen, Univ Childrens Hosp, Tubingen, Germany
关键词
Turner syndrome; Phenotype; Karyotype; Growth Hormone Treatment; Safety; BONE-MINERAL DENSITY; PREMATURE OVARIAN FAILURE; RANDOMIZED DOSE-RESPONSE; LONG-TERM MORTALITY; QUALITY-OF-LIFE; ADULT HEIGHT; SHORT STATURE; BODY PROPORTIONS; FINAL HEIGHT; FOLLOW-UP;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Turner Syndrome (TS) is a rare disorder, characterized by numerous signs and symptoms, which are also highly variable in their expression in individuals. The understanding of the genetic basis of the phenotype has advanced greatly during the past decades. The most consistent features, which negatively affect the quality of life in these individuals, are short stature and impaired gonadal function. After recombinant human growth hormone (rhGH) became available and was shown to improve height, it was then approved and has been used widely. Yet it remains a challenge to decide on the optimal treatment modality for individuals with TS and to evaluate the benefits and risks also in terms of karyotype of GH on growth and on other organ systems. This article reviews some of the major aspects related to these issues.
引用
收藏
页码:356 / 365
页数:10
相关论文
共 50 条
  • [41] Components of the metabolic syndrome in girls with Turner syndrome treated with growth hormone in a long term prospective study
    Blaszczyk, Ewa
    Shulhai, Anna-Mariia
    Gieburowska, Joanna
    Baranski, Kamil
    Gawlik, Aneta Monika
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [42] Carbohydrate metabolism during growth hormone treatment and after discontinuation of growth hormone treatment in girls with Turner syndrome treated with once or twice daily growth hormone injections
    Sas, T
    de Muinck Keizer-Schrama, S
    Aanstoot, HJ
    Stijnen, T
    Drop, S
    CLINICAL ENDOCRINOLOGY, 2000, 52 (06) : 741 - 747
  • [43] Growth hormone supplementation in Turner's syndrome
    Van Vliet, G
    Deal, C
    JOURNAL OF PEDIATRICS, 1998, 133 (06): : 803 - 803
  • [44] The role of growth hormone therapy in Turner syndrome
    Sas, Theo C. J.
    de Muinck Keizer-Schrama, Sabine M. P. F.
    INDIAN JOURNAL OF PEDIATRICS, 2008, 75 (01): : S9 - S13
  • [45] Response to growth hormone therapy in Turner syndrome
    Ozgen, Ilker Tolga
    Adal, Erdal
    Unuvar, Tolga
    Onal, Hasan
    Sarikaya, Aliye Sevil
    Akin, Leyla
    TURK PEDIATRI ARSIVI-TURKISH ARCHIVES OF PEDIATRICS, 2013, 48 (04): : 294 - 298
  • [46] The impact of growth hormone therapy on Turner syndrome
    Rosenfeld, RG
    THERAPEUTIC OUTCOME OF ENDOCRINE DISORDERS: EFFICACY, INNOVATION AND QUALITY OF LIFE, 2000, : 63 - 68
  • [47] Growth hormone therapy in patients with Turner syndrome
    Haeusler, G
    HORMONE RESEARCH, 1998, 49 : 62 - 66
  • [48] Osteodensitometry in Turner syndrome and growth hormone deficiency
    Battin, J
    Barthe, N
    Barat, P
    ARCHIVES DE PEDIATRIE, 1997, 4 : S95 - S101
  • [49] GROWTH-HORMONE TREATMENT IN TURNER SYNDROME
    ZVULUNOV, A
    EUROPEAN JOURNAL OF PEDIATRICS, 1994, 153 (12) : 919 - 919
  • [50] Carbohydrate and lipid metabolism during various growth hormone dosing regimens in girls with Turner syndrome
    van Teunenbroek, A
    Keizer-Schrama, SMPFD
    Aanstoot, HJ
    Stijnen, T
    Hoogerbrugge, N
    Drop, SLS
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1999, 48 (01): : 7 - 14